Literature DB >> 15716192

Diabetes mellitus and the risk of prostate cancer in Italy.

A Tavani1, S Gallus, M Bertuzzi, L Dal Maso, A Zucchetto, E Negri, S Franceschi, V Ramazzotti, M Montella, C La Vecchia.   

Abstract

OBJECTIVE: We investigated the relation between diabetes and the risk of prostate cancer, as epidemiological results are controversial.
METHODS: A hospital-based case-control study was conducted in Italy between 1991 and 2002. Cases were 1294 men, aged <75 years, with incident histologically confirmed prostate cancer, and controls were 1451 men, aged <75 years, admitted to hospital for acute non-neoplastic diseases. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression models.
RESULTS: No material association between diabetes and prostate cancer was observed, with a multivariate OR of 1.02 (95%CI 0.75-1.40). Prostate cancer was not related to time since diagnosis of diabetes (OR 0.82 and 0.97 for <5 and >/=15 years since diagnosis respectively). The OR were respectively 1.63 (95%CI 0.70-3.81) and 0.96 (95%CI 0.68-1.34) in men diagnosed with diabetes at age <45 or >/=45 years. The risk estimates were similar across strata of age at interview, body mass index and, among cases, of Gleason score.
CONCLUSIONS: This study shows no material association between diabetes and prostate cancer risk.

Entities:  

Mesh:

Year:  2005        PMID: 15716192     DOI: 10.1016/j.eururo.2004.10.027

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

2.  Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.

Authors:  Jocelyn S Kasper; Yan Liu; Edward Giovannucci
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

3.  Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan.

Authors:  Cheng-Chieh Lin; Jen-Huai Chiang; Chia-Ing Li; Chiu-Shong Liu; Wen-Yuan Lin; Teng-Fu Hsieh; Tsai-Chung Li
Journal:  BMC Cancer       Date:  2014-05-29       Impact factor: 4.430

4.  Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Authors:  Michael F Leitzmann; Jiyoung Ahn; Demetrius Albanes; Ann W Hsing; Arthur Schatzkin; Shih-Chen Chang; Wen-Yi Huang; Jocelyn M Weiss; Kim N Danforth; Robert L Grubb; Gerald L Andriole
Journal:  Cancer Causes Control       Date:  2008-07-10       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.